Literature DB >> 20701816

Quality of life in dementia patients in Athens, Greece: predictive factors and the role of caregiver-related factors.

Antonis A Mougias1, Antonis Politis, Constantine G Lyketsos, Venetsanos G Mavreas.   

Abstract

BACKGROUND: Quality of life (QOL) is increasingly recognized as the main target of currently available dementia care. Its assessment has grown exponentially in the dementia field, but few studies have examined predictive factors for QOL taking caregiver variables into account. We examined patient and caregiver factors related to the QOL of dementia patients.
METHODS: The study design was cross-sectional. 161 couples of community residing dementia patients and their primary caregivers were interviewed. QOL was measured by the ADRQL, a proxy-rated, dementia-specific QOL instrument. Demographic factors were collected and clinical characteristics assessed using validated scales.
RESULTS: In univariate analyses several patient and caregiver characteristics appeared associated with patient QOL. In multivariate analyses, independent predictors of worse patient QOL were behavioral and depressive symptoms of dementia patients, dependency in basic activities of daily living, poorer cognitive function, use of antipsychotic medication, caregiver burden, and caregiver not being an adult child. The adjusted R2 of the final, seven-factor model was 0.598.
CONCLUSIONS: QOL for a person with dementia is a complex issue that is associated with several patient and caregiver factors. Efforts to improve patients' QOL should be addressed for both patients and caregivers. The measurement of QOL should be included, when possible, as a standard measurement tool, in everyday dementia clinical practice.

Entities:  

Mesh:

Year:  2010        PMID: 20701816     DOI: 10.1017/S1041610210001262

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

1.  Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures.

Authors:  Betty S Black; Deirdre Johnston; Ann Morrison; Peter V Rabins; Constantine G Lyketsos; Quincy M Samus
Journal:  Qual Life Res       Date:  2011-10-26       Impact factor: 4.147

2.  Predictors of quality of life ratings for persons with dementia simultaneously reported by patients and their caregivers: the Cache County (Utah) Study.

Authors:  Trevor Buckley; Elizabeth B Fauth; Ann Morrison; Joann Tschanz; Peter V Rabins; Kathleen W Piercy; Maria Norton; Constantine G Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-03-14       Impact factor: 3.878

3.  Antihypertensive Use and the Risk of Alzheimer's Disease and Related Dementias among Older Adults in the USA.

Authors:  Xi Pan; Donglan Zhang; Ji Haeng Heo; Chanhyun Park; Gang Li; Christine M Dengler-Crish; Yan Li; Yian Gu; Henry N Young; Devin L Lavender; Lu Shi
Journal:  Drugs Aging       Date:  2022-10-17       Impact factor: 4.271

Review 4.  Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review.

Authors:  Amir Abbas Tahami Monfared; Genevieve Meier; Richard Perry; Darren Joe
Journal:  Neurol Ther       Date:  2019-09-12

5.  Health-related quality of life in the Cambridge City over-75s Cohort (CC75C): development of a dementia-specific scale and descriptive analyses.

Authors:  Jaime Perales; Theodore D Cosco; Blossom C M Stephan; Jane Fleming; Steven Martin; Josep Maria Haro; Carol Brayne
Journal:  BMC Geriatr       Date:  2014-02-10       Impact factor: 3.921

6.  Care staff and family member perspectives on quality of life in people with very severe dementia in long-term care: a cross-sectional study.

Authors:  Linda Clare; Catherine Quinn; Zoe Hoare; Rhiannon Whitaker; Robert T Woods
Journal:  Health Qual Life Outcomes       Date:  2014-12-09       Impact factor: 3.186

Review 7.  Quality of Life in Patients with Dementia with Lewy Bodies.

Authors:  Chuo-Yu Lee; Shih-Jung Cheng; Hui-Chi Lin; Yu-Lu Liao; Pei-Hao Chen
Journal:  Behav Neurol       Date:  2018-07-05       Impact factor: 3.342

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.